Related Experiment Video
Updated: May 13, 2026

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with rifaximin
P Lutz1, M Parcina, I Bekeredjian-Ding
1Department of Internal Medicine I, University of Bonn, Sigmund-Freud-Str. 25, 53129, Bonn, Germany, philipp.lutz@ukb.uni-bonn.de.
Abstract:
Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis. Recently, rifaximin, a non-absorbable antibiotic which is used to prevent recurrent hepatic encephalopathy, has been proposed as effective prophylaxis for SBP. Here, we present an unusual case of SBP under treatment with rifaximin. A 50-year-old woman with liver cirrhosis was admitted because of tense ascites and abdominal pain. She was under long-term oral prophylaxis with rifaximin due to hepatic encephalopathy. Paracentesis revealed SBP caused by Pasteurella multocida, which was sensitive to multiple antibiotics, including rifaximin. Treatment with ceftriaxone resulted in rapid resolution of the peritonitis and restoration of the patient. Since P. multocida is usually transmitted from pets, the patient's cat was tested and could be identified as the most likely source of infection. This case should elicit our awareness that uncommon pathogens and unusual routes of transmission may lead to SBP, despite antibacterial prophylaxis with non-absorbable antibiotics. Nevertheless, such infections may still remain sensitive to systemic therapy with conventional antibiotics.
Insights
Spontaneous bacterial peritonitis (SBP) can occur despite rifaximin prophylaxis. This case highlights uncommon pathogens like Pasteurella multocida, often from pets, causing SBP, which still responds to antibiotics.
Area of Science:
- Hepatology
- Infectious Diseases
- Microbiology
Background:
- Spontaneous bacterial peritonitis (SBP) is a serious complication in liver cirrhosis patients.
- Rifaximin, a non-absorbable antibiotic, is used for hepatic encephalopathy and proposed for SBP prophylaxis.
- This study examines an SBP case occurring during rifaximin prophylaxis.
Observation:
- A liver cirrhosis patient on rifaximin prophylaxis presented with ascites and abdominal pain.
- Paracentesis revealed SBP caused by Pasteurella multocida.
- The patient's cat was identified as the likely source of Pasteurella multocida infection.
Findings:
- Pasteurella multocida, an uncommon SBP pathogen, was identified.
- The isolated pathogen was sensitive to multiple antibiotics, including rifaximin.
- Ceftriaxone treatment led to rapid resolution of SBP.
Implications:
- Awareness of unusual pathogens and transmission routes for SBP is crucial, even with prophylaxis.
- Non-absorbable antibiotic prophylaxis does not eliminate all SBP risks.
- Systemic antibiotic therapy remains effective for SBP caused by sensitive organisms.
